Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
07/2014
07/30/2014EP2757886A1 Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
07/30/2014CN103959502A 有机发光元件及使用其的迟滞荧光材料以及化合物 The organic light emitting device using the same, and the delayed fluorescent material and the compound
07/30/2014CN103958504A 新的10a型磷酸二酯酶抑制剂化合物 10a new phosphodiesterase type inhibitor compound
07/30/2014CN103958503A 作为用于治疗帕金森病的激酶lrrk2调节剂的2-(苯基或吡啶-3-基)氨基嘧啶衍生物 As used in the treatment of Parkinson's disease 2- lrrk2 kinase modulators (phenyl or pyridin-3-yl) amino-pyrimidine derivatives
07/30/2014CN103958502A 作为丝氨酸/苏氨酸激酶抑制剂的喹唑啉化合物 As a serine / threonine kinase inhibitor quinazoline compounds
07/30/2014CN103958500A 蛋白激酶抑制剂 Protein kinase inhibitors
07/30/2014CN103958498A 作为lrrk2调节剂的氨基嘧啶衍生物 As the amino-pyrimidine derivatives lrrk2 modifier
07/30/2014CN103958481A 可用于治疗的哒嗪衍生物 Pyridazine derivatives useful in the treatment of
07/30/2014CN103958049A 包括水解去保护步骤和固相萃取的<sup>18</sup>F-标记化合物的纯化 Including the hydrolysis step to protect and SPE <sup> purified 18 </ sup> F- labeled compound
07/30/2014CN103951705A 一种以咔唑为核的具有蝴蝶形状的双极性小分子主体材料及制备方法 A nuclear carbazole bipolar host material of small molecules and the preparation method has a butterfly shape
07/30/2014CN103951658A 用于治疗异常细胞生长的磺酰胺衍生物 Sulfonamide derivatives for the treatment of abnormal cell growth
07/30/2014CN103951657A 一种高电负性有机半导体 A highly electronegative organic semiconductors
07/30/2014CN103951621A 一种蓝色有机发光二极管材料 One kind of blue organic light-emitting diode material
07/30/2014CN103949185A 一种具备杀菌活性的阴离子表面活性剂及其制备方法 One kind possess bactericidal activity of anionic surfactant and its preparation method
07/30/2014CN103948594A 用于治疗癌症的化合物 Compounds for the treatment of cancer
07/30/2014CN102753533B 咪唑烷二酮衍生物 Imidazolidine dione derivative
07/30/2014CN102731417B 内核为炔基、外层为氨基酸的树状分子及其Huisgen 1,3-偶极环加成合成方法与应用 Kernel alkynyl, the outer layer of the tree amino acid molecules Huisgen 1,3- dipolar cycloaddition synthesis and the application
07/30/2014CN102432599B 一种二肽基肽酶抑制剂的草酸盐晶型及其制备方法和用途 Oxalate crystal form and method for preparing dipeptidyl peptidase inhibitors and uses
07/30/2014CN102365020B 哒嗪酮化合物 Pyridazinone compound
07/30/2014CN102131813B 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法 Biocatalytic process for preparing a substantially pure stereoisomer of the fused bicyclic proline compounds
07/30/2014CN102066362B 二氢吲哚酮衍生物 Indolinone derivatives
07/30/2014CN101965342B N-[2-(二乙基氨基)乙基]-5-[(5-氟-1,2-二氢-2-氧代-3h-吲哚-3-亚基)甲基]-2,4-二甲基-1h-吡咯-3-甲酰胺的晶型及其制备方法 N- [2- (diethylamino) ethyl] -5 - [(5-fluoro-1,2-dihydro-2-oxo -3h- indol-3-ylidene) methyl] -2 , 4-dimethyl-pyrrole-3-carboxylic acid polymorph -1h- and preparation method of the amide
07/30/2014CN101511823B 多功能生物活性化合物 Multifunctional bioactive compounds
07/30/2014CN101374817B 作为胆甾醇酯转移蛋白cetp的抑制剂的三取代的胺化合物 Tri-substituted amine compound as cholesteryl ester transfer protein inhibitors cetp
07/29/2014US8791260 Process for the preparation of acylguanidines and acylthioureas
07/29/2014US8791257 Substituted pyrrolotriazines as protein kinase inhibitors
07/29/2014US8791149 Methods of treating traumatic brain injury using pro-neurogenic compounds
07/29/2014US8791143 Anthranilic diamide derivatives having cyclic side-chains
07/29/2014US8791121 Oligooxopiperazines and methods of making and using them
07/29/2014US8791120 Fast-dissociating dopamine 2 receptor antagonists
07/29/2014US8791114 Dihydropyrazoles
07/29/2014US8791111 Piperidine and piperazine derivatives
07/29/2014US8791103 Carboxylic acid amides, the preparation thereof and their use as medicaments
07/29/2014US8791102 Acetanilide sphingosine-1-phosphate receptor antagonists
07/29/2014US8790621 Nanoparticles and nanoparticle compositions
07/29/2014CA2593993C Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/24/2014WO2014113794A2 Oligooxopiperazines for p53 reactivation
07/24/2014WO2014113717A1 Voriconazole immunoassays
07/24/2014WO2014113620A2 Phthalazinones and isoquinolinones as rock inhibitors
07/24/2014WO2014111839A1 Pyrrole derivatives as alpha 7 nachr modulators
07/24/2014US20140206862 Antioxidant Small Molecules Aimed at Targeting Metal-Based Oxidative Stress in Neurogenerative Disorders
07/24/2014US20140206706 Five-membered heterocycles useful as serine protease inhibitors
07/24/2014US20140206701 Selective subtype alpha 2 adrenergic agents and methods for use thereof
07/24/2014US20140206694 Heterocyclic compounds and their uses
07/24/2014US20140206688 Amino quinazolines as kinase inhibitors
07/24/2014US20140206686 Phthalazinones and isoquinolinones as rock inhibitors
07/24/2014US20140206676 Substituted 4-(1h-pyrazol-4-yl)benzyl analogues as positive allosteric modulators of machr m1 receptors
07/24/2014US20140206660 Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
07/24/2014US20140205655 OLIGOOXOPIPERAZINES FOR p53 REACTIVATION
07/24/2014US20140205564 Hepatitis C Virus Inhibitors
07/24/2014US20140205537 Lrrk2 inhibitors
07/23/2014EP2757104A1 Compounds used in the synthesis of oxazolidinones
07/23/2014EP2757086A1 Hydrocarbon-based fused ring compound and organic light emitting device using the same
07/23/2014EP2755966A2 Bimetallic catalysts for co2 hydrogenation and h2 generation from formic acid and/or salts thereof
07/23/2014EP2755960A1 Plant growth regulating compounds
07/23/2014EP2755958A1 Aminopyrimidine derivatives for use as modulators of kinase activity
07/23/2014CN103946213A 作为组织蛋白酶抑制剂的新吡咯烷衍生物 Cathepsin inhibitors as new pyrrolidine derivatives
07/23/2014CN103936722A 一种咔唑取代的吩嗪类化合物及其制备方法和用途 One kind of carbazole substituted phenazine compounds and their preparation and use
07/23/2014CN103936721A 咔唑衍生物取代的吩嗪类化合物及其制备方法和用途 Carbazole derivatives substituted phenazine compounds and their preparation and use
07/23/2014CN103936720A 含有螺芴结构单元的化合物及其制备方法与应用 Compound and its preparation method and application of structural units containing spirofluorene
07/23/2014CN103936654A 一类脱氢枞酸吲哚衍生物的用途 Use of a class of dehydroabietic acid indole derivatives
07/23/2014CN103396407B 一种坎地沙坦酯晶体的制备方法 A method for preparing candesartan ester crystals
07/23/2014CN103396406B 一种坎地沙坦酯的制备方法 A method for preparing candesartan ester
07/23/2014CN103265534B 阿伐那非的制备方法 Preparation avanaphil of
07/23/2014CN103254180B 一种阿伐那非的制备方法 A method of preparing avanaphil of
07/23/2014CN102884048B 用作hcn阻滞剂的氨基杂芳基衍生物 Blockers used hcn amino heteroaryl derivatives
07/23/2014CN102666489B 鞘氨醇激酶抑制剂 Sphingosine kinase inhibitors
07/23/2014CN102643269B 一类含吡唑结构的磷脂酶a2抑制剂及用途 Pyrazole structure of a class of phospholipase a2 inhibitors and uses
07/23/2014CN102633782B 双母体叠合型紫外线吸收剂及其制备方法 UV absorbers superimposed dual parent and its preparation method
07/23/2014CN102177141B 作为丙型肝炎病毒抑制剂的联-1h-苯并咪唑 As inhibitors of hepatitis C virus associated -1h--benzimidazole
07/23/2014CN102137858B 5-脂氧合酶-活化蛋白抑制剂 5-lipoxygenase - activating protein inhibitor
07/23/2014CN102105462B 可用作c-met的抑制剂的酰胺基苯氧基吲唑 Useful as inhibitors of c-met phenoxy indazole amide
07/23/2014CN102105437B 金刚烷基二酰胺衍生物及其应用 Adamantyl diamide derivatives and their Applications
07/23/2014CN101932574B 用于治疗对多巴胺D<sub>3</sub>受体调节产生反应的病症的1,2,4-三嗪-3,5-二酮化合物 For the treatment of dopamine D <sub> 3 </ sub> receptor modulators of the reaction conditions to produce a 1,2,4-triazine-3,5-dione compound
07/23/2014CN101838262B 具有杂芳环的咔唑衍生物及使用它的发光元件及发光装置 Carbazole derivatives having a heteroaromatic ring and the use of its light-emitting element and a light-emitting device
07/22/2014US8785643 Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
07/22/2014US8785628 Triazine derivatives as kinase inhibitors
07/22/2014US8785489 Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
07/22/2014US8785478 Viral polymerase inhibitors
07/22/2014US8785459 Quinazoline compounds as kinase inhibitors
07/22/2014US8785448 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
07/22/2014US8785447 Use of dopamine D3 receptor ligands for the production of drugs for treating renal function disorders
07/22/2014US8785003 Material for organic electroluminescence device and organic electroluminescence device using the same
07/22/2014CA2654218C Process for the preparation of pure irbesartan
07/17/2014WO2014110298A1 5-membered heteroaryls and their use as antiviral agents
07/17/2014WO2014110297A1 (hetero) arylacetamide derivatives as antiretroviral agents
07/17/2014WO2014108679A1 Benzylamine derivatives
07/17/2014WO2014108337A1 Pyrazolyl-based carboxamides i as crac channel inhibitors
07/17/2014WO2014108336A1 Pyrazolyl-based carboxamides ii as crac channel inhibitors
07/17/2014WO2014108299A1 Substituted [1,2,4]triazole and imidazole compounds
07/17/2014US20140200343 Process and intermediates for preparing macrolactams
07/17/2014US20140200333 Dendron reporter molecules
07/17/2014US20140200232 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use
07/17/2014US20140200226 Anti-malarial compounds from marine natural products
07/17/2014US20140200223 Inhibitors of beta-secretase
07/17/2014US20140200221 Novel polymorphic forms of 3-(1--6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride salt and processes of manufacturing thereof
07/16/2014EP2754660A1 Pyridazinon derivatives
07/16/2014EP2754659A1 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof
07/16/2014EP2754656A1 Androgen receptor modulating compounds
07/16/2014EP2753606A1 Pyrimidines as sodium channel blockers
1 ... 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 ... 626